▮ More

Wall Street Events

Sysco Q4 21 Earnings Conference Call At 10:00 AM ET

By RTTNews Staff Writer ✉ | Published: 8/10/2021 6:00 AM ET

Sysco Corp. (SYY) will host a conference call at 10:00 AM ET on August 10, 2021, to discuss Q4 21 earnings results. Sysco is scheduled to report results on Tuesday, August 10, before market open.

To access the live webcast, log on to http://investors.sysco.com

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In October 2022

Biotech Stocks Facing FDA Decision In September

Biotech Stocks Facing FDA Decision In June 2022

Latest Updates on COVID-19

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways

Covid Conditions Improving Nationally In US, Data Shows

Pfizer, BioNTech Apply For EUA In US Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Kids

Synairgen Reports Positive 60 And 90-day Long COVID Data From Phase 3 SNG001 Trial; Stock Up

U.S. Covid Cases Fall 29% In Last Fortnight

COVID-19: Drugs in Development

Tesla Starts Semi Production; First Delivery To Pepsi In Dec.

Ford Hikes Price Of F-150 Lightning Electric Pickup Again

Tyson To Move Corporate Jobs In Chicago, Downers Grove, Dakota Dunes To Arkansas

Virgin Orbit Says Its Latest Rocket Is Ready For Flight

FAA Extends Rest Periods For Flight Attendants

Hilton To Feature Peloton Bikes Across All 5,400 U.S. Hotels

Zerto Fontal Cheese, Brie And Camembert Cheeses Recalled

Sysco Q4 21 Earnings Conference Call At 10:00 AM ET

Tesla Starts Semi Production; First Delivery To Pepsi In Dec.

Ford Hikes Price Of F-150 Lightning Electric Pickup Again

Tyson To Move Corporate Jobs In Chicago, Downers Grove, Dakota Dunes To Arkansas

Virgin Orbit Says Its Latest Rocket Is Ready For Flight

FAA Extends Rest Periods For Flight Attendants

Hilton To Feature Peloton Bikes Across All 5,400 U.S. Hotels

Zerto Fontal Cheese, Brie And Camembert Cheeses Recalled

Tesla Q3 Vehicle Production, Deliveries Up

Pineapple Energy Surges More Than 80%

RedHill Says Its Oral Antivirals, Opaganib And RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5

Gilead Company Kite Says FDA Oks RVV Manufacturing Facility In California For Commercial Production

Amazon To Decarbonize Its Fleet With Electric Heavy Goods Vehicles From Volvo

Myovant Sciences Rejects $2.5 Bln Offer From Sumitovant And Sumitomo Pharma

Medical Properties To Sell Connecticut Hospitals To Prospect Medical Holdings

Tesla Starts Semi Production; First Delivery To Pepsi In Dec.

ABB Completes Spin-off Of Accelleron Industries

Clene Reports Topline Results For CNM-Au8 In Healey ALS Platform Trial

FDA Approves Lyell Immunopharma's IND For LYL845; Shares Up 8%

Holcim Buys Polymers Sealants North America From Illinois Tool Works

Prosus Reveals Termination Of $4.7 Bln Deal To Buy India's BillDesk

Porsche Becomes Most Valuable Car Maker In Europe

Quanergy Board Approves Reverse Stock Split - Quick Facts

RS Group Expects Full Year Revenue, Adj. Profit Slightly Ahead Of Consensus Expectations

RPM International Q1 Results Top Estimate; Guides Q2 Sales

Merck Group Says On Track To Hit EUR 25 Bln Sales Target By 2025

Imperial Brands To Start £1Bln Share Buyback, Affirms Trading In Line With View

Chemring Group Says Trading In Line With Expectations

Aquaron Acquisition Prices IPO Of 5 Mln Units At $10.00/unit

Cigna Expands Medicare Advantage Plans For 2023 With 22% Growth In Geographic Footprint

Alnylam's Oxlumo Indicated For Treatment Of PH1 To Lower Urinary And Plasma Oxalate Levels

Everi To Buy Certain Strategic Assets Of Venuetize